Search research articles
Contact Us
Filters
Showing results (21-30 of 37) with videos related to
Page
of 4
Sort By:
Glia
|
April 9, 2021
Investigating oligodendrocyte connexins: Heteromeric interactions between Cx32 and mutant or wild-type forms of Cx47 do not contribute to or modulate gap junction function
Charles K Abrams, Rafael E Flores-Obando, Gabriel D Dungan, et al.
Experimental Neurology
|
November 20, 2022
Knock-in mouse models for CMTX1 show a loss of function phenotype in the peripheral nervous system
Charles K Abrams, Eunjoo Lancaster, Jian J Li, et al.
Scientific Reports
|
January 11, 2017
Loss of Coupling Distinguishes GJB1 Mutations Associated with CNS Manifestations of CMT1X from Those Without CNS Manifestations
Charles K Abrams, Mikhail Goman, Sarah Wong, et al.
Acta Neuropathologica Communications
|
September 3, 2016
Systemic inflammation disrupts oligodendrocyte gap junctions and induces ER stress in a model of CNS manifestations of X-linked Charcot-Marie-Tooth disease
Margarita Olympiou, Irene Sargiannidou, Kyriaki Markoullis, et al.
Glia
|
October 17, 2018
Regulatory role of oligodendrocyte gap junctions in inflammatory demyelination
Christos P Papaneophytou, Elena Georgiou, Christos Karaiskos, et al.
American Journal of Physiology. Cell Physiology
|
July 26, 2018
Alterations at Arg<sup>76</sup> of human connexin 46, a residue associated with cataract formation, cause loss of gap junction formation but preserve hemichannel function
Charles K Abrams, Alejandro Peinado, Rola Mahmoud, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience
|
November 25, 2003
Pathogenesis of X-linked Charcot-Marie-Tooth disease: differential effects of two mutations in connexin 32
Charles K Abrams, Mona Freidin, Feliksas Bukauskas, et al.
ACS Pharmacology & Translational Science
|
February 17, 2023
Pharmacologic Targeting of the C-Terminus of Heat Shock Protein 90 Improves Neuromuscular Function in Animal Models of Charcot Marie Tooth X1 Disease
Sukhmanjit Kaur, Xinyue Zhang, Sugandha Patel, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
March 22, 2006
Properties of human connexin 31, which is implicated in hereditary dermatological disease and deafness
Charles K Abrams, Mona M Freidin, Vytas K Verselis, et al.
Journal of Neurology
|
July 26, 2014
A new mutation in GJC2 associated with subclinical leukodystrophy
Charles K Abrams, Steven S Scherer, Rafael Flores-Obando, et al.
Page
of 4
Search research articles
Search
Showing results (21-30 of 37) with videos related to
Sort By:
Page
of 4
Glia
|
April 9, 2021
Investigating oligodendrocyte connexins: Heteromeric interactions between Cx32 and mutant or wild-type forms of Cx47 do not contribute to or modulate gap junction function
Charles K Abrams, Rafael E Flores-Obando, Gabriel D Dungan, et al.
Experimental Neurology
|
November 20, 2022
Knock-in mouse models for CMTX1 show a loss of function phenotype in the peripheral nervous system
Charles K Abrams, Eunjoo Lancaster, Jian J Li, et al.
Scientific Reports
|
January 11, 2017
Loss of Coupling Distinguishes GJB1 Mutations Associated with CNS Manifestations of CMT1X from Those Without CNS Manifestations
Charles K Abrams, Mikhail Goman, Sarah Wong, et al.
Acta Neuropathologica Communications
|
September 3, 2016
Systemic inflammation disrupts oligodendrocyte gap junctions and induces ER stress in a model of CNS manifestations of X-linked Charcot-Marie-Tooth disease
Margarita Olympiou, Irene Sargiannidou, Kyriaki Markoullis, et al.
Glia
|
October 17, 2018
Regulatory role of oligodendrocyte gap junctions in inflammatory demyelination
Christos P Papaneophytou, Elena Georgiou, Christos Karaiskos, et al.
American Journal of Physiology. Cell Physiology
|
July 26, 2018
Alterations at Arg<sup>76</sup> of human connexin 46, a residue associated with cataract formation, cause loss of gap junction formation but preserve hemichannel function
Charles K Abrams, Alejandro Peinado, Rola Mahmoud, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience
|
November 25, 2003
Pathogenesis of X-linked Charcot-Marie-Tooth disease: differential effects of two mutations in connexin 32
Charles K Abrams, Mona Freidin, Feliksas Bukauskas, et al.
ACS Pharmacology & Translational Science
|
February 17, 2023
Pharmacologic Targeting of the C-Terminus of Heat Shock Protein 90 Improves Neuromuscular Function in Animal Models of Charcot Marie Tooth X1 Disease
Sukhmanjit Kaur, Xinyue Zhang, Sugandha Patel, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
March 22, 2006
Properties of human connexin 31, which is implicated in hereditary dermatological disease and deafness
Charles K Abrams, Mona M Freidin, Vytas K Verselis, et al.
Journal of Neurology
|
July 26, 2014
A new mutation in GJC2 associated with subclinical leukodystrophy
Charles K Abrams, Steven S Scherer, Rafael Flores-Obando, et al.
Page
of 4